Synthetic Nitrile vs Latex Condoms for STI Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare synthetic nitrile condoms to standard latex condoms in preventing sexually transmitted infections (STIs). Participants will use two sizes of synthetic nitrile condoms and a latex condom to determine which is most effective. Eligible participants must be in a monogamous relationship for at least three months, be sexually active, and be willing to use the study condoms and lubricant as instructed. As an unphased trial, this study allows participants to contribute to important research that could enhance sexual health options.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that synthetic nitrile condoms are generally safe and effective. Studies have found that these condoms break and slip at rates similar to latex condoms, making them equally reliable in preventing sexually transmitted infections (STIs).
Information about acrylonitrile, a chemical used in these condoms, suggests no consistent link between this chemical and cancer in humans, indicating a good safety profile.
Overall, synthetic nitrile condoms appear well-tolerated based on available data. They offer a safe alternative to latex condoms, especially for those with latex allergies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about synthetic nitrile condoms because they offer a unique alternative to traditional latex condoms. Unlike latex, nitrile is a synthetic material that can be an excellent option for people with latex allergies. Nitrile condoms are also designed to provide a different fit and feel, with options in both 53mm and 56mm widths, potentially enhancing comfort and satisfaction. This exploration into nitrile condoms could expand choices for consumers and improve overall sexual health by offering effective STI prevention without the risk of latex-induced allergic reactions.
What evidence suggests that this trial's treatments could be effective for STI prevention?
Research has shown that synthetic nitrile condoms, like polyurethane ones, have breakage and slippage rates similar to latex condoms. This similarity indicates they are equally effective in preventing sexually transmitted infections (STIs). Regular condom use can reduce the risk of some infections, such as chlamydia, by about 33%. This trial will compare the effectiveness of synthetic nitrile condoms, available in 53mm and 56mm sizes, with traditional latex condoms. Early results suggest that both sizes of synthetic nitrile condoms are as effective as latex condoms in preventing STIs.12467
Who Is on the Research Team?
Mags Beksinska, PhD
Principal Investigator
MatCH Research Unit (MRU)
Are You a Good Fit for This Trial?
Couples aged 18-45, in a monogamous relationship for at least 3 months, who are sexually active and agree to use only study condoms and lubricant. Excludes those with allergies to latex or nitrile, STI symptoms or HIV positive status, pregnant women or those wanting pregnancy soon, participants in other condom studies, employees of the trial's institutions, sex workers, men with sexual dysfunction and individuals with genital piercings.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use five synthetic nitrile condoms (53 mm width), five synthetic nitrile condoms (56 mm width), and five latex male condoms in a randomised order, completing a Condom Use Report after each use.
Follow-up
Participants are monitored for functional performance, safety, and acceptability of the condoms used.
What Are the Treatments Tested in This Trial?
Interventions
- Control Latex Condom
- Synthetic Nitrile Condoms (53mm)
- Synthetic Nitrile Condoms (56mm)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Karex Industries Sdn. Bhd.
Lead Sponsor
University of Witwatersrand, South Africa
Collaborator
Essential Access Health
Collaborator
Sigma3 Services SARL
Collaborator